Seeking Real-World Data on Whether Aducanumab Works
Alzforum,
13 Aug 2021 The Food and Drug Administration’s conditional approval of aducanumab (Aduhelm) left most researchers and…
13 Aug 2021 The Food and Drug Administration’s conditional approval of aducanumab (Aduhelm) left most researchers and…
06 Aug 2021 The FDA’s controversial approval of aducanumab hinged on the premise that clearance of amyloid would be “reasonably…